MICHAEL E GELLERT
CIK 1018650 · last filed 2017-11-13
MICHAEL E GELLERT is a corporate insider who has filed 6 SEC Form 4 insider transactions across 1 company since 2017. The most recent filing, for APLS, was dated Nov 13, 2017.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | 10%+ Owner | 943,989 | $41.03 | $38.73M | $0 | 1 | 2017-11-13 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-11-13 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Conv (C) | +798,068 | $0 | EDGAR |
| 2010-05-20 | — | Exer (M) | +3,000 | $129.0K | |
| 2009-05-20 | — | Grant (A) | +500 | $0 | |
| 2008-06-06 | — | Grant (A) | +500 | $0 | |
| 2007-05-21 | — | Grant (A) | +500 | $0 | |
| 2007-05-21 | — | Grant (A) | +500 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.